• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change.载脂蛋白 B、小而密 LDL-C、脂蛋白(a)、脂蛋白相关磷脂酶 A 活性与认知改变。
Neurology. 2019 May 28;92(22):e2580-e2593. doi: 10.1212/WNL.0000000000007574. Epub 2019 May 1.
2
Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.缓释烟酸对他汀治疗患者高密度脂蛋白(HDL)功能、脂蛋白代谢及血管炎症介质的影响。
J Am Heart Assoc. 2015 Sep 15;4(9):e001508. doi: 10.1161/JAHA.114.001508.
3
Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk.与CETP抑制剂和他汀类药物相关的基因变异与脂蛋白水平及心血管风险的关联
JAMA. 2017 Sep 12;318(10):947-956. doi: 10.1001/jama.2017.11467.
4
Lipoprotein(a) Mass Levels Increase Significantly According to Genotype: An Analysis of 431 239 Patients.脂蛋白(a)质量水平根据基因型显著升高:对431239例患者的分析
Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):580-588. doi: 10.1161/ATVBAHA.116.308704. Epub 2017 Jan 5.
5
Relationship of apoE polymorphism with lipoprotein(a), apoA, apoB and lipid levels in atherosclerotic infarct.载脂蛋白E基因多态性与动脉粥样硬化性梗死中脂蛋白(a)、载脂蛋白A、载脂蛋白B及血脂水平的关系
J Neurol Sci. 2009 Feb 15;277(1-2):17-21. doi: 10.1016/j.jns.2008.09.034. Epub 2008 Oct 21.
6
Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.与其他类型的高胆固醇血症相比,确诊的家族性高胆固醇血症患者的脂蛋白相关磷脂酶A₂活性升高。
Nutr Metab Cardiovasc Dis. 2018 May;28(5):517-523. doi: 10.1016/j.numecd.2018.01.012. Epub 2018 Feb 2.
7
Differential effect of hypolipidemic drugs on lipoprotein-associated phospholipase A2.降血脂药物对脂蛋白相关磷脂酶A2的差异作用。
Arterioscler Thromb Vasc Biol. 2007 Oct;27(10):2236-43. doi: 10.1161/ATVBAHA.107.147280. Epub 2007 Jul 26.
8
Discordance between lipoprotein (a) and LDL-cholesterol levels in cardiovascular risk assessment in apparently healthy subjects.脂蛋白(a)与 LDL 胆固醇水平在貌似健康人群心血管风险评估中的不相符性。
Nutr Metab Cardiovasc Dis. 2023 Jul;33(7):1429-1436. doi: 10.1016/j.numecd.2023.04.010. Epub 2023 Apr 14.
9
Lipoprotein(a) and risk-weighted apolipoprotein B: a novel metric for atherogenic risk.脂蛋白(a)和风险加权载脂蛋白 B:一种新的动脉粥样硬化风险指标。
Lipids Health Dis. 2024 Sep 27;23(1):316. doi: 10.1186/s12944-024-02307-6.
10
Gender-specific association of coronary artery calcium and lipoprotein parameters: the Heinz Nixdorf Recall Study.冠状动脉钙与脂蛋白参数的性别特异性关联:Heinz Nixdorf 回顾研究。
Atherosclerosis. 2013 Aug;229(2):531-40. doi: 10.1016/j.atherosclerosis.2013.04.015. Epub 2013 May 3.

引用本文的文献

1
Integrated plasma and red blood cell membrane lipidomics analysis unveils novel biomarker panel for Alzheimer's disease.血浆和红细胞膜脂质组学综合分析揭示阿尔茨海默病新生物标志物组合
Alzheimers Res Ther. 2025 Jul 30;17(1):178. doi: 10.1186/s13195-025-01830-7.
2
Association of Blood Lipoprotein Levels With Incident Alzheimer Disease in Community-Dwelling Individuals: The Framingham Heart Study.社区居住个体的血脂蛋白水平与阿尔茨海默病发病的关联:弗雷明汉心脏研究
Neurology. 2025 Jun 24;104(12):e213715. doi: 10.1212/WNL.0000000000213715. Epub 2025 May 30.
3
Elevated lipoprotein-associated phospholipase A2 as a biomarker for cognitive impairment in chronic kidney disease.脂蛋白相关磷脂酶A2升高作为慢性肾脏病认知障碍的生物标志物
Int Urol Nephrol. 2025 Apr 1. doi: 10.1007/s11255-025-04469-3.
4
Circulating Blood-Based Proteins in Psychopathology and Cognition: A Mendelian Randomization Study.精神病理学与认知中的循环血液蛋白:一项孟德尔随机化研究
JAMA Psychiatry. 2025 May 1;82(5):481-491. doi: 10.1001/jamapsychiatry.2025.0033.
5
Modulatory Effect of Blood LDL Cholesterol on the Association between Cerebral Aβ and Tau Deposition in Older Adults.血液 LDL 胆固醇对老年人脑 Aβ 和 Tau 沉积相关性的调节作用。
J Prev Alzheimers Dis. 2024;11(6):1767-1774. doi: 10.14283/jpad.2024.131.
6
Vascular cognitive impairment: Advances in clinical research and management.血管性认知障碍:临床研究与管理进展
Chin Med J (Engl). 2024 Dec 5;137(23):2793-2807. doi: 10.1097/CM9.0000000000003220. Epub 2024 Jul 24.
7
Research advances in the influence of lipid metabolism on cognitive impairment.脂质代谢对认知障碍影响的研究进展
Ibrain. 2022 Feb 18;10(1):83-92. doi: 10.1002/ibra.12018. eCollection 2024 Spring.
8
Profile of Lipoprotein Subclasses in Chinese Primary Open-Angle Glaucoma Patients.中国原发性开角型青光眼患者脂蛋白亚类特征
Int J Mol Sci. 2024 Apr 21;25(8):4544. doi: 10.3390/ijms25084544.
9
Higher serum Lp-PLA2 is associated with cognitive impairment in Parkinson's disease patients.血清Lp-PLA2水平升高与帕金森病患者的认知障碍有关。
Front Neurosci. 2024 Mar 12;18:1374567. doi: 10.3389/fnins.2024.1374567. eCollection 2024.
10
Large-Scale Mendelian Randomization Study Reveals Circulating Blood-based Proteomic Biomarkers for Psychopathology and Cognitive Task Performance.大规模孟德尔随机化研究揭示了基于循环血液的精神病理学和认知任务表现的蛋白质组学生物标志物。
medRxiv. 2024 Jan 19:2024.01.18.24301455. doi: 10.1101/2024.01.18.24301455.

本文引用的文献

1
Association of midlife lipids with 20-year cognitive change: A cohort study.中年血脂与 20 年认知变化的关系:一项队列研究。
Alzheimers Dement. 2018 Feb;14(2):167-177. doi: 10.1016/j.jalz.2017.07.757. Epub 2017 Sep 12.
2
Hypercholesterolemia induced cerebral small vessel disease.高胆固醇血症诱发脑小血管病。
PLoS One. 2017 Aug 10;12(8):e0182822. doi: 10.1371/journal.pone.0182822. eCollection 2017.
3
Hypercholesterolaemia and vascular dementia.高胆固醇血症与血管性痴呆
Clin Sci (Lond). 2017 Jun 30;131(14):1561-1578. doi: 10.1042/CS20160382. Print 2017 Jul 15.
4
The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.脂蛋白(a)与首次心力衰竭住院的关联:社区动脉粥样硬化风险研究
Atherosclerosis. 2017 Jul;262:131-137. doi: 10.1016/j.atherosclerosis.2017.05.014. Epub 2017 May 12.
5
Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study.从儿童期到中年的心血管危险因素与认知表现:芬兰年轻人研究。
J Am Coll Cardiol. 2017 May 9;69(18):2279-2289. doi: 10.1016/j.jacc.2017.02.060.
6
Low LDL cholesterol, and genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study.低密度脂蛋白胆固醇、基因变异与阿尔茨海默病和帕金森病风险:孟德尔随机化研究
BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.
7
A Test in Context: Lipoprotein(a): Diagnosis, Prognosis, Controversies, and Emerging Therapies.在语境中检验:脂蛋白(a):诊断、预后、争议和新兴疗法。
J Am Coll Cardiol. 2017 Feb 14;69(6):692-711. doi: 10.1016/j.jacc.2016.11.042.
8
Multiple imputation of cognitive performance as a repeatedly measured outcome.将认知表现作为重复测量结果进行多重填补。
Eur J Epidemiol. 2017 Jan;32(1):55-66. doi: 10.1007/s10654-016-0197-8. Epub 2016 Sep 12.
9
Is lipoprotein (a) protective of dementia?脂蛋白(a)对痴呆有保护作用吗?
Eur J Epidemiol. 2016 Nov;31(11):1149-1152. doi: 10.1007/s10654-016-0184-0. Epub 2016 Jul 13.
10
Lipoprotein associated phospholipase A2 activity, apolipoprotein C3 loss-of-function variants and cardiovascular disease: The Atherosclerosis Risk In Communities Study.脂蛋白相关磷脂酶A2活性、载脂蛋白C3功能丧失变异与心血管疾病:社区动脉粥样硬化风险研究
Atherosclerosis. 2015 Aug;241(2):641-8. doi: 10.1016/j.atherosclerosis.2015.06.033. Epub 2015 Jun 18.

载脂蛋白 B、小而密 LDL-C、脂蛋白(a)、脂蛋白相关磷脂酶 A 活性与认知改变。

ApoB, small-dense LDL-C, Lp(a), LpPLA activity, and cognitive change.

机构信息

From Saint Luke's Mid-America Heart Institute (Y.P.), University of Missouri-Kansas City; Department of Epidemiology and Biostatistics (F.M., M.C.P.), George Washington University Milken Institute School of Public Health, Washington, DC; Department of Epidemiology (F.M., A.A.), Rollins School of Public Health, Emory University, Atlanta, GA; Section of Cardiology (V.N., S.S.V.), Michael E. DeBakey Veterans Affairs Medical Center; Section of Cardiology (V.N., S.S.V., R.H., C.M.B.), Baylor College of Medicine; Center for Cardiovascular Disease Prevention (V.N., S.S.V., R.H., C.M.B.), Houston Methodist DeBakey Heart and Vascular Center, TX; Department of Epidemiology (G.H.), Gillings School of Global Public Health, University of North Carolina, Chapel Hill; Department of Epidemiology (J.C., R.F.G.), Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD; Department of Medicine (T.M.), University of Mississippi Medical Center, Jackson; Department of Neurology (R.F.G.), Johns Hopkins University, Baltimore, MD.

出版信息

Neurology. 2019 May 28;92(22):e2580-e2593. doi: 10.1212/WNL.0000000000007574. Epub 2019 May 1.

DOI:10.1212/WNL.0000000000007574
PMID:31043469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6556082/
Abstract

OBJECTIVE

To examine the association of specific lipoproteins/inflammatory enzyme with cognitive change.

METHODS

We examined the association of apolipoprotein B (ApoB), small-dense low-density lipoprotein cholesterol (sdLDL-C), lipoprotein (a) (Lp[a]), and lipoprotein-associated phospholipase A (LpPLA) activity with 15-year change in Delayed Word Recall Test, Digit Symbol Substitution Test (DSST), Word Fluency Test (WFT), and overall summary score in 9,350 participants in the Atherosclerosis Risk in Communities study. We assessed interaction by race, sex, education, ε4 status, and statin use. We also addressed questions of informative missingness, the role of stroke, and the influence of fasting status.

RESULTS

The mean (SD) age was 63.4 (5.7) years; 56.4% were women and 17.4% were black. We observed faster cognitive decline on DSST and global scores with every 10-mg/dL higher sdLDL-C level (Δ DSST score, -0.010; 95% confidence interval [CI] -0.017, -0.002 and Δ global score, -0.011; -0.021, -0.001) and the highest vs the lowest ApoB quintiles (Δ DSST score, -0.092; -0.0164, -0.019 and Δ global score, -0.101; -0.200, -0.002). Association for the ApoB quintiles with Δ global score (-0.10) was comparable with that of having 1 ε4 allele (-0.11). Higher Lp(a) was associated with slower decline in DSST, WFT, and global scores. LpPLA activity was not associated with cognitive change. Results were similar in sensitivity analyses. The associations of sdLDL-C or Lp(a) on cognitive change were more pronounced in statin users.

CONCLUSIONS

Optimal control of atherogenic lipoproteins such as ApoB and sdLDL-C in midlife for cardiovascular health may also benefit late-life cognitive health.

摘要

目的

探讨特定脂蛋白/炎症酶与认知变化的关系。

方法

我们研究了载脂蛋白 B (ApoB)、小而密低密度脂蛋白胆固醇 (sdLDL-C)、脂蛋白(a) (Lp[a])和脂蛋白相关磷脂酶 A (LpPLA)活性与动脉粥样硬化风险社区研究 9350 名参与者 15 年延迟单词回忆测试、数字符号替代测试 (DSST)、单词流畅性测试 (WFT)和总综合评分变化之间的关系。我们通过种族、性别、教育程度、ε4 状态和他汀类药物使用情况评估了相互作用。我们还解决了信息缺失、中风作用和空腹状态的影响问题。

结果

参与者的平均(SD)年龄为 63.4(5.7)岁,56.4%为女性,17.4%为黑人。我们观察到,随着 sdLDL-C 水平每增加 10mg/dL,DSST 和全球评分的认知下降速度加快(DSST 评分的变化,-0.010;95%置信区间 [CI] -0.017,-0.002 和全球评分的变化,-0.011;-0.021,-0.001),以及 ApoB 五分位数的最高值与最低值之间(DSST 评分的变化,-0.092;-0.0164,-0.019 和全球评分的变化,-0.101;-0.200,-0.002)。ApoB 五分位数与 Δ 全球评分(-0.10)的关联与携带 1 个 ε4 等位基因(-0.11)相当。较高的 Lp(a)与 DSST、WFT 和全球评分下降较慢相关。LpPLA 活性与认知变化无关。敏感性分析结果相似。他汀类药物使用者的 sdLDL-C 或 Lp(a)对认知变化的影响更为显著。

结论

中年控制动脉粥样硬化脂蛋白,如 ApoB 和 sdLDL-C,对心血管健康有益,也可能有益于晚年认知健康。